Carducci MA - Search Results

1

New Treatment Options for Patients With Metastatic Prostate Cancer: What Is The Optimal Sequence?

van Dodewaard-de Jong JM, Verheul HMW, Bloemendal HJ, de Klerk JMH, Carducci MA, van den Eertwegh AJM. van Dodewaard-de Jong JM, et al. Among authors: carducci ma. Clin Genitourin Cancer. 2015 Aug;13(4):271-279. doi: 10.1016/j.clgc.2015.01.008. Epub 2015 Jan 21. Clin Genitourin Cancer. 2015. PMID: 25704270 Review.

2

Prostate cancer treatment strategies based on tumor-specific biological principles: future directions.

Carducci MA, DeWeese TL, Nelson WG, Simons JW, Sinibaldi V, Eisenberger MA. Carducci MA, et al. Semin Oncol. 1996 Dec;23(6 Suppl 14):56-62. Semin Oncol. 1996. PMID: 8996587 Review.

3

Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer.

Sinibaldi VJ, Carducci M, Laufer M, Eisenberger M. Sinibaldi VJ, et al. Semin Oncol. 1999 Oct;26(5 Suppl 17):45-8. Semin Oncol. 1999. PMID: 10604269 Clinical Trial.

4

Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer.

Laufer M, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: carducci ma. Urology. 1999 Oct;54(4):745. doi: 10.1016/s0090-4295(99)00268-x. Urology. 1999. PMID: 10754148 Free article.

5

Complete androgen blockade for prostate cancer: what went wrong?

Laufer M, Denmeade SR, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: carducci ma. J Urol. 2000 Jul;164(1):3-9. J Urol. 2000. PMID: 10840412 Free article. Review.

6

Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis.

Pili R, Kruszewski MP, Hager BW, Lantz J, Carducci MA. Pili R, et al. Among authors: carducci ma. Cancer Res. 2001 Feb 15;61(4):1477-85. Cancer Res. 2001. PMID: 11245454

7

Phase II evaluation of docetaxel plus one-day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma.

Sinibaldi VJ, Carducci MA, Moore-Cooper S, Laufer M, Zahurak M, Eisenberger MA. Sinibaldi VJ, et al. Among authors: carducci ma. Cancer. 2002 Mar 1;94(5):1457-65. doi: 10.1002/cncr.10350. Cancer. 2002. PMID: 11920502 Free article. Clinical Trial.

8

Long-term effects of androgen deprivation therapy in prostate cancer patients.

Basaria S, Lieb J 2nd, Tang AM, DeWeese T, Carducci M, Eisenberger M, Dobs AS. Basaria S, et al. Clin Endocrinol (Oxf). 2002 Jun;56(6):779-86. doi: 10.1046/j.1365-2265.2002.01551.x. Clin Endocrinol (Oxf). 2002. PMID: 12072048

9

Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges.

Rosenbaum E, Carducci MA. Rosenbaum E, et al. Among authors: carducci ma. Expert Opin Pharmacother. 2003 Jun;4(6):875-87. doi: 10.1517/14656566.4.6.875. Expert Opin Pharmacother. 2003. PMID: 12783585 Review.

10

Endothelin receptor antagonists in the treatment of prostate cancer.

Lassiter LK, Carducci MA. Lassiter LK, et al. Among authors: carducci ma. Semin Oncol. 2003 Oct;30(5):678-88. doi: 10.1016/s0093-7754(03)00353-1. Semin Oncol. 2003. PMID: 14571415 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters